MBX 1416 (INN imapextide)
MBX-1P2002
Phase 2 small_molecule active
Quick answer
MBX 1416 (INN imapextide) for Postbariatric Hypoglycemia is a Phase 2 program (small_molecule) at MBX Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MBX Biosciences
- Indication
- Postbariatric Hypoglycemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active